- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 58.74M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 63.11M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $8K |
| Capex restated | Q1 2025 · Mar 31, 2024 | $29K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $1.22M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$17.9M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $67.23M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $67.15M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $53.2M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $50.2M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $25.02M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $22.63M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $87.1M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $66.87M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $179.13M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $198.51M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $266.23M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $265.38M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.31 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.44 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.31 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.52 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $16.16M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $17.05M |
| Net Income | Q1 2025 · Mar 31, 2025 | $18.18M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $24.94M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$2.03M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$960K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $14.13M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $16.09M |
| Revenue | Q1 2025 · Mar 31, 2025 | $87M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $100.84M |